Table 3.

Parameters of Glycemic Variability from the Retrospective Continuous Glucose Monitoring System.

Indexes	Control Patients	Transplanted Patients	P Value
HbA1c (mmol, %)	71 ± 10 (8.7 ± 1.0)	41 ± 6 (5.9 ± 0.6)	0.004*
Clarke score	5 ± 1	0	0.001*
Sensor glucose mean (mg/dL)	212 ± 47	109 ± 16	0.012*
Coefficient variation (%)	37 ± 7	13 ± 2	0.012*
Standard deviation (mg/dL)	77 ± 11	15 ± 4	0.012*
AUC (min mg/dL)	1,058 ± 235	545 ± 79	0.012*
MAGE (mg/dL)	1.2 ± 0.2	0.3 ± 0.1	0.012*
CONGA-4	94 ± 10	19 ± 8	0.012*
MODD (mg/dL)	66 ± 40	11 ± 4	0.037*
HBGI	19.8 ± 7.6	0.7 ± 0.5	0.012*
LBGI	5.9 ± 4.1	1.2 ± 1.1	0.022*
BGRI	18 ± 7	1 ± 1	0.012*
ADRR	71 ± 9	10 ± 4	0.012*
J index	86 ± 31	16 ± 5	0.012*
Time in range (%)	31 ± 15	99 ± 2	0.008*

Note: Glucose values are expressed in mg/dL. Data are expressed as mean ± standard deviation. Abbreviations: AUC, the area under the curve of glycemic values; MAGE, the mean amplitude of glucose excursion; CONGA-4, the continuous overall net glycemic action of the previous 4 h; MODD, the mean of daily differences; HBGI, the high blood glucose index; LBGI, the low blood glucose index; ADRR, the average daily risk range; BGRI, the blood glucose risk index.

*Indicates P value ≤ 0.05.